WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 2047

Legislative bill overview

SB 2047 regulates pharmacy benefit managers (PBMs) in Hawaii, the intermediaries that manage prescription drug benefits for insurance plans. The bill has passed the Health and Human Services Committee with amendments and is advancing toward further consideration in the budget committee.

Why is this important

PBMs significantly influence drug prices, pharmacy reimbursement rates, and patient access to medications. This legislation could affect medication costs and availability for Hawaii residents, as well as the operations and profitability of pharmacies and PBM companies in the state.

Potential points of contention

  • PBM profit margins vs. drug affordability: Stricter regulations may increase transparency but could lead PBMs to argue restrictions harm their business model or increase administrative costs passed to consumers
  • Pharmacy compensation concerns: Independent pharmacies often advocate for higher reimbursement rates from PBMs, which could conflict with insurers' cost-control priorities
  • Interstate commerce implications: Heavily regulating PBMs operating across state lines may face legal challenges or industry pushback regarding the limits of Hawaii's regulatory authority

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.